Prospective studies have provided some evidence of beneficial effects of Se on the risk of lung, bladder, colorectal, liver, esophagus, cardio-gastric, thyroid, and prostate cancers, but these results are sometimes disparate [77]
Ipamorelin Selectivity The Case for GHS-R1a Addition Research establishing Ipamorelins profile confirmed it does not raise cortisol, prolactin, ACTH, FSH, LH, or TSH at doses that produce robust GH release with its selectivity for GH-only secretion confirmed even at doses more than 200-fold above the ED50 for GH release
Compounded GIP/GLP-1 dual-agonist, 2.5mg to 15mg weekly across six dose levels
Across all studies, the safety profile was consistent with the broader GLP-1 class: nausea, diarrhea, and mild gastrointestinal symptoms were the most common side effects, typically occurring during the dose escalation phase
Our quick and secure registration process ensures we have all the information needed to provide you with the best care possible
It presents that gap as a reflection of the safety and efficacy evaluation new medications require